Daytrana Patch
Product Images NDC 68968-5553

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Daytrana (NDC 68968-5553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Noven Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daytrana-structure (Daytrana 01)

Chemical structure of methylphenidate, the active ingredient in Daytrana transdermal patches. The diagram shows the molecular arrangement including a phenyl ring, piperidine ring, and an ester functional group with a methoxy substituent.*

FDA Label Image

Daytrana-figure-cross-section (Daytrana 02)

An illustration diagram showing the layers of a Daytrana methylphenidate transdermal patch. The labeled layers include the outside backing, an adhesive layer containing methylphenidate, and a protective liner that is removed before application.*

FDA Label Image

Daytrana-figure1 (Daytrana 03)

A line graph depicting mean concentration-time profiles of d-Methylphenidate in patients following single applications of Daytrana patches at 10 mg, 20 mg, and 30 mg strengths over a 9-hour wear time. The y-axis represents d-Methylphenidate concentration in ng/mL, and the x-axis indicates time in hours after patch application, showing peak concentrations around 10-12 hours.*

FDA Label Image

Daytrana-ppi-fig1 (Daytrana 04)

An instructional line drawing showing a hand pulling aside clothing at the upper thigh to reveal application of a transdermal patch. The image illustrates how to apply a Daytrana methylphenidate transdermal patch to the thigh area.*

FDA Label Image

Daytrana-ppi-fig2 (Daytrana 05)

An instructional illustration showing a person using scissors to cut a square patch, with one hand holding the patch and the other cutting along its edge. The image demonstrates how to trim or modify a transdermal patch, consistent with the usage of Daytrana methylphenidate patch.*

FDA Label Image

Daytrana-patch (Daytrana 06)

Illustration showing the Daytrana methylphenidate transdermal patch with its labeled parts: the adhesive layer containing the medicine, a protective liner being peeled off, and the outside backing with the printed Daytrana name on the opposite side.*

FDA Label Image

Daytrana-ppi-fig3 (Daytrana 07)

An instructional diagram showing hands peeling apart a rectangular patch, likely a transdermal medication patch. The illustration suggests removing the backing from the patch to prepare it for application to the skin.*

FDA Label Image

Daytrana-ppi-fig4 (Daytrana 08)

An instructional illustration showing hands applying a Daytrana methylphenidate transdermal patch to the hip area of a person's body. The image demonstrates the patch placement and application technique for the transdermal delivery system.*

FDA Label Image

Daytrana-ppi-fig5 (Daytrana 09)

Illustration showing hands peeling a Daytrana methylphenidate transdermal patch from its protective liner, demonstrating proper patch preparation for application.*

FDA Label Image

Daytrana-ppi-fig6 (Daytrana 10)

An instructional illustration showing a person applying a transdermal patch to the hip area. The image demonstrates proper placement of a Daytrana methylphenidate patch on the skin, indicating correct hand positioning during application.*

FDA Label Image

Daytrana-10mg-30ct-carton (Daytrana 11)

Daytrana 10 mg/9h transdermal patch packaging label from Noven Therapeutics, LLC. The label features the Daytrana name and methylphenidate indication with dosage strength and duration. It indicates the box contains 30 patches, details proper usage to be worn for approximately 9 hours, and includes manufacturer information and a dosing chart.*

FDA Label Image

Daytrana-15mg-30ct-carton (Daytrana 12)

The Daytrana 15 mg/9h (1.6 mg/hr) transdermal patch packaging label displays the proprietary name, generic methylphenidate, and indicates it is a patch for transdermal use. The label states the package contains 30 patches and includes the Noven Therapeutics, LLC labeler name along with dosage strength and instructions to wear patches for approximately 9 hours.*

FDA Label Image

Daytrana-20mg-30ct-carton (Daytrana 13)

Daytrana 20 mg/9 hours (methylphenidate transdermal system) patch packaging label by Noven Therapeutics, LLC. The label states the patch delivers 20 mg over 9 hours (2.2 mg/hr) and contains 30 patches. The design features dosing and administration information along with the NDC 68968-5543-3 and trademarked Daytrana logos.*

FDA Label Image

Daytrana-30mg-30ct-carton (Daytrana 14)

Daytrana 30 mg/9 hours transdermal patch packaging label by Noven Therapeutics, LLC. The label indicates the patch delivers 30 mg of methylphenidate over 9 hours (3.3 mg/hr) and contains 30 patches per package. The box is primarily dark blue with white text, includes dosage and handling instructions, and features the Daytrana logo prominently.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.